-
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Thursday, June 20, 2024 - 12:15pm | 399Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to acquire the exclusive rights for advanced cannabis products. Under the deal, current Remidose...